<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">medgen</journal-id><journal-title-group><journal-title xml:lang="ru">Медицинская генетика</journal-title><trans-title-group xml:lang="en"><trans-title>Medical Genetics</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2073-7998</issn><publisher><publisher-name>Publishing House «Genius Media» LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.25557/2073-7998.2022.05.3-17</article-id><article-id custom-type="elpub" pub-id-type="custom">medgen-2177</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>НАУЧНЫЙ ОБЗОР</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>REVIEW</subject></subj-group></article-categories><title-group><article-title>Е-кадгерин в опухолевой прогрессии рака желудка</article-title><trans-title-group xml:lang="en"><trans-title>Е-cadherin in gastric cancer tumorigenesis</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Немцова</surname><given-names>М. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Nemtsova</surname><given-names>M. V.</given-names></name></name-alternatives><email xlink:type="simple">nemtsova_m_v@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Буре</surname><given-names>И. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Bure</surname><given-names>I. V.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Залетаев</surname><given-names>Д. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Zaletaev</surname><given-names>D. V.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кузнецова</surname><given-names>Е. Б.</given-names></name><name name-style="western" xml:lang="en"><surname>Kuznetsova</surname><given-names>E. B.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ветчинкина</surname><given-names>Е. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Vetchinkina</surname><given-names>E. A.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Молчанов</surname><given-names>А. Д.</given-names></name><name name-style="western" xml:lang="en"><surname>Molchanov</surname><given-names>A. D.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГАОУ ВО Первый Московский государственный медицинский университет имени И.М. Сеченова Министерства здравоохранения Российской Федерации (Сеченовский Университет); ФГБНУ «Медико-генетический научный центр имени академика Н.П. Бочкова»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University);  Research Centre for Medical Genetics</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФГАОУ ВО Первый Московский государственный медицинский университет имени И.М. Сеченова Министерства здравоохранения Российской Федерации (Сеченовский Университет)</institution><country>Россия</country></aff><aff xml:lang="en"><institution>I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University)</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>ФГБНУ «Медико-генетический научный центр имени академика Н.П. Бочкова»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Research Centre for Medical Genetics</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2022</year></pub-date><pub-date pub-type="epub"><day>09</day><month>12</month><year>2022</year></pub-date><volume>21</volume><issue>5</issue><fpage>3</fpage><lpage>17</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Немцова М.В., Буре И.В., Залетаев Д.В., Кузнецова Е.Б., Ветчинкина Е.А., Молчанов А.Д., 2022</copyright-statement><copyright-year>2022</copyright-year><copyright-holder xml:lang="ru">Немцова М.В., Буре И.В., Залетаев Д.В., Кузнецова Е.Б., Ветчинкина Е.А., Молчанов А.Д.</copyright-holder><copyright-holder xml:lang="en">Nemtsova M.V., Bure I.V., Zaletaev D.V., Kuznetsova E.B., Vetchinkina E.A., Molchanov A.D.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.medgen-journal.ru/jour/article/view/2177">https://www.medgen-journal.ru/jour/article/view/2177</self-uri><abstract><p>В основе инвазии и метастазирования опухолевых клеток лежит эпителиально-мезенхимальный переход (ЭМП). При этом состоянии происходит потеря связи между эпителиальными клетками и появляется подвижный фенотип, характерный для мезенхимальных клеток. Важную роль в процессе ЭМП играет белок Е-кадгерин, который устанавливает и поддерживает межклеточные взаимодействия и позволяет эпителиальным клеткам формировать клеточный пласт. Частичная или полная потеря экспрессии E-кадгерина, происходящая при ЭМП, опосредована механизмами, которые блокируют экспрессию активаторов белка и связанных с ним транскрипционных факторов. Напротив, происходит гиперэкспрессия генов его блокаторов SNAIL1/2, ZEB, TWIST1, GRHL2, OVOL1/2 и PRRX1. E-кадгерин задействован в различных онкогенных сигнальных путях, таких как Wnt/β-catenin, Rho GTPase и EGF/EGFR, благодаря чему он способствует развитию многих опухолей, включая рак желудка (РЖ). Важнейшие компоненты эпигенетического контроля экспрессии генов при канцерогенезе - микроРНК и длинные некодирующие РНК - участвуют в регуляции функции Е-кадгерина. Они действуют непосредственно или опосредованно, через многочисленные факторы, контролирующие транскрипцию гена, и таким образом влияют на пролиферацию и метастазирование опухолевых клеток. Этот обзор посвящен роли E-кадгерина в опухолевой прогрессии, а также участию некодирующих РНК в механизмах его экспрессионного контроля при канцерогенезе желудка.</p></abstract><trans-abstract xml:lang="en"><p>Epithelial-mesenchymal transition (EMT) is the basis of tumor invasion and metastasis. It is characterized by the loss of communication between epithelial cells, which lead to the appearance of a motile phenotype of mesenchymal cells. The E-cadherin protein plays an important role in the EMT process, establishing and maintaining intercellular interactions and allowing epithelial cells to form a cell layer. The partial or complete loss of E-cadherin expression that occurs during EMT is mediated by mechanisms that block the expression of activators of this protein and related transcription factors. In contrast, the inhibitors of E-cadherin SNAIL1/2, ZEB, TWIST1, GRHL2, OVOL1/2, and PRRX1 are overexpressed. E-cadherin is involved in various oncogenic signaling pathways such as Wnt/β-catenin, Rho GTPase and EGF/EGFR. Therefore it contributes to many tumors, including gastric cancer (GC). MicroRNAs and long noncoding RNAs as important epigenetic regulators of gene expression in carcinogenesis are also involved in the regulation of E-cadherin function. They act directly or indirectly, through multiple factors controlling gene transcription, and thus influence tumor cell proliferation and metastasis. This review is focused on the role of E-cadherin in tumor progression and the involvement of non-coding RNAs in the mechanisms controlling its expression in gastric carcinogenesis.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>Е-кадгерин</kwd><kwd>эпителиально-мезенхимальный переход (ЭМП)</kwd><kwd>нарушение экспрессии</kwd><kwd>опухолевая прогрессия</kwd><kwd>рак желудка</kwd><kwd>некодирующие РНК</kwd></kwd-group><kwd-group xml:lang="en"><kwd>E-cadherin</kwd><kwd>epithelial-mesenchymal transition (EMT)</kwd><kwd>aberrant gene expression</kwd><kwd>tumor progression</kwd><kwd>gastric cancer</kwd><kwd>noncoding RNAs</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Canel M., Serrels A., Frame M.C., et al. E-Cadherin-Integrin Crosstalk in Cancer Invasion and Metastasis. J. Cell Sci. 2013;126(Pt 2):393-401. https://doi.org/10.1242/JCS.100115.</mixed-citation><mixed-citation xml:lang="en">Canel M., Serrels A., Frame M.C., et al. E-Cadherin-Integrin Crosstalk in Cancer Invasion and Metastasis. J. Cell Sci. 2013;126(Pt 2):393-401. https://doi.org/10.1242/JCS.100115.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Ratheesh A., Yap A.S. A Bigger Picture: Classical Cadherins and the Dynamic Actin Cytoskeleton. Nat. Rev. Mol. Cell Biol. 2012;13(10):673-679. https://doi.org/10.1038/NRM3431.</mixed-citation><mixed-citation xml:lang="en">Ratheesh A., Yap A.S. A Bigger Picture: Classical Cadherins and the Dynamic Actin Cytoskeleton. Nat. Rev. Mol. Cell Biol. 2012;13(10):673-679. https://doi.org/10.1038/NRM3431.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Aban C.E., Lombardi A., Neiman G., et al. Downregulation of E-Cadherin in Pluripotent Stem Cells Triggers Partial EMT. Sci. Rep. 2021;11(1):. https://doi.org/10.1038/S41598-021-81735-1.</mixed-citation><mixed-citation xml:lang="en">Aban C.E., Lombardi A., Neiman G., et al. Downregulation of E-Cadherin in Pluripotent Stem Cells Triggers Partial EMT. Sci. Rep. 2021;11(1):. https://doi.org/10.1038/S41598-021-81735-1.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Nieto M.A., Huang R.Y.Y.J., Jackson R.A.A., et al. EMT: 2016. Cell 2016;166(1):21-45. https://doi.org/10.1016/J.CELL.2016.06.028.</mixed-citation><mixed-citation xml:lang="en">Nieto M.A., Huang R.Y.Y.J., Jackson R.A.A., et al. EMT: 2016. Cell 2016;166(1):21-45. https://doi.org/10.1016/J.CELL.2016.06.028.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Frías A., Lambies G., Viñas-Castells R., et al. A Switch in Akt Isoforms Is Required for Notch-Induced Snail1 Expression and Protection from Cell Death. Mol. Cell. Biol. 2016;36(6):923-940. https://doi.org/10.1128/MCB.01074-15/ASSET/8492B277-4B06-41CF-977E-E5B0BD7AA269/ASSETS/GRAPHIC/ZMB9991011590012.JPEG.</mixed-citation><mixed-citation xml:lang="en">Frías A., Lambies G., Viñas-Castells R., et al. A Switch in Akt Isoforms Is Required for Notch-Induced Snail1 Expression and Protection from Cell Death. Mol. Cell. Biol. 2016;36(6):923-940. https://doi.org/10.1128/MCB.01074-15/ASSET/8492B277-4B06-41CF-977E-E5B0BD7AA269/ASSETS/GRAPHIC/ZMB9991011590012.JPEG.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Chen A., Beetham H., Black M.A., et al. E-Cadherin Loss Alters Cytoskeletal Organization and Adhesion in Non-Malignant Breast Cells but Is Insufficient to Induce an Epithelial-Mesenchymal Transition. BMC Cancer 2014;14(1):. https://doi.org/10.1186/1471-2407-14-552.</mixed-citation><mixed-citation xml:lang="en">Chen A., Beetham H., Black M.A., et al. E-Cadherin Loss Alters Cytoskeletal Organization and Adhesion in Non-Malignant Breast Cells but Is Insufficient to Induce an Epithelial-Mesenchymal Transition. BMC Cancer 2014;14(1):. https://doi.org/10.1186/1471-2407-14-552.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Hollestelle A., Peeters J.K., Smid M., et al. Loss of E-Cadherin Is Not a Necessity for Epithelial to Mesenchymal Transition in Human Breast Cancer. Breast Cancer Res. Treat. 2013;138(1):47-57. https://doi.org/10.1007/S10549-013-2415-3.</mixed-citation><mixed-citation xml:lang="en">Hollestelle A., Peeters J.K., Smid M., et al. Loss of E-Cadherin Is Not a Necessity for Epithelial to Mesenchymal Transition in Human Breast Cancer. Breast Cancer Res. Treat. 2013;138(1):47-57. https://doi.org/10.1007/S10549-013-2415-3.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Villarejo A., Cortés-Cabrera Á., Molina-Ortíz P., et al. Differential Role of Snail1 and Snail2 Zinc Fingers in E-Cadherin Repression and Epithelial to Mesenchymal Transition. J. Biol. Chem. 2014;289(2):930-941. https://doi.org/10.1074/JBC.M113.528026.</mixed-citation><mixed-citation xml:lang="en">Villarejo A., Cortés-Cabrera Á., Molina-Ortíz P., et al. Differential Role of Snail1 and Snail2 Zinc Fingers in E-Cadherin Repression and Epithelial to Mesenchymal Transition. J. Biol. Chem. 2014;289(2):930-941. https://doi.org/10.1074/JBC.M113.528026.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang Z., Yang C., Gao W., et al. FOXA2 Attenuates the Epithelial to Mesenchymal Transition by Regulating the Transcription of E-Cadherin and ZEB2 in Human Breast Cancer. Cancer Lett. 2015;361(2):240-250. https://doi.org/10.1016/J.CANLET.2015.03.008.</mixed-citation><mixed-citation xml:lang="en">Zhang Z., Yang C., Gao W., et al. FOXA2 Attenuates the Epithelial to Mesenchymal Transition by Regulating the Transcription of E-Cadherin and ZEB2 in Human Breast Cancer. Cancer Lett. 2015;361(2):240-250. https://doi.org/10.1016/J.CANLET.2015.03.008.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Alotaibi H., Basilicata M.F., Shehwana H., et al. Enhancer Cooperativity as a Novel Mechanism Underlying the Transcriptional Regulation of E-Cadherin during Mesenchymal to Epithelial Transition. Biochim. Biophys. Acta 2015;1849(6):731-742. https://doi.org/10.1016/J.BBAGRM.2015.01.005.</mixed-citation><mixed-citation xml:lang="en">Alotaibi H., Basilicata M.F., Shehwana H., et al. Enhancer Cooperativity as a Novel Mechanism Underlying the Transcriptional Regulation of E-Cadherin during Mesenchymal to Epithelial Transition. Biochim. Biophys. Acta 2015;1849(6):731-742. https://doi.org/10.1016/J.BBAGRM.2015.01.005.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Wong S.H.M., Fang C.M., Chuah L.H., et al. E-Cadherin: Its Dysregulation in Carcinogenesis and Clinical Implications. Crit. Rev. Oncol. Hematol. 2018;121:11-22. https://doi.org/10.1016/J.CRITREVONC.2017.11.010.</mixed-citation><mixed-citation xml:lang="en">Wong S.H.M., Fang C.M., Chuah L.H., et al. E-Cadherin: Its Dysregulation in Carcinogenesis and Clinical Implications. Crit. Rev. Oncol. Hematol. 2018;121:11-22. https://doi.org/10.1016/J.CRITREVONC.2017.11.010.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Christiansen J.J., Rajasekaran A.K. Reassessing Epithelial to Mesenchymal Transition as a Prerequisite for Carcinoma Invasion and Metastasis. Cancer Res. 2006;66(17):8319-8326. https://doi.org/10.1158/0008-5472.CAN-06-0410.</mixed-citation><mixed-citation xml:lang="en">Christiansen J.J., Rajasekaran A.K. Reassessing Epithelial to Mesenchymal Transition as a Prerequisite for Carcinoma Invasion and Metastasis. Cancer Res. 2006;66(17):8319-8326. https://doi.org/10.1158/0008-5472.CAN-06-0410.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Cavallaro U., Christofori G. Cell Adhesion and Signalling by Cadherins and Ig-CAMs in Cancer. Nat. Rev. Cancer 2004 42 2004;4(2):118-132. https://doi.org/10.1038/nrc1276.</mixed-citation><mixed-citation xml:lang="en">Cavallaro U., Christofori G. Cell Adhesion and Signalling by Cadherins and Ig-CAMs in Cancer. Nat. Rev. Cancer 2004 42 2004;4(2):118-132. https://doi.org/10.1038/nrc1276.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Pan Y, Bi F, Liu N, et al. Expression of Seven Main Rho Family Members in Gastric Carcinoma. Biochem. Biophys. Res.Commun. 2004;315(3):686-691. https://doi.org/10.1016/J.BBRC.2004.01.108.</mixed-citation><mixed-citation xml:lang="en">Pan Y, Bi F, Liu N, et al. Expression of Seven Main Rho Family Members in Gastric Carcinoma. Biochem. Biophys. Res.Commun. 2004;315(3):686-691. https://doi.org/10.1016/J.BBRC.2004.01.108.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Zhan T., Rindtorff N., Boutros M. Wnt Signaling in Cancer. Oncogene 2017;36(11):1461-1473. https://doi.org/10.1038/ONC.2016.304.</mixed-citation><mixed-citation xml:lang="en">Zhan T., Rindtorff N., Boutros M. Wnt Signaling in Cancer. Oncogene 2017;36(11):1461-1473. https://doi.org/10.1038/ONC.2016.304.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Yong X., Tang B., Li B.S., et al. Helicobacter Pylori Virulence Factor CagA Promotes Tumorigenesis of Gastric Cancer via Multiple Signaling Pathways. Cell Commun. Signal. 2015;13(1):. https://doi.org/10.1186/S12964-015-0111-0.</mixed-citation><mixed-citation xml:lang="en">Yong X., Tang B., Li B.S., et al. Helicobacter Pylori Virulence Factor CagA Promotes Tumorigenesis of Gastric Cancer via Multiple Signaling Pathways. Cell Commun. Signal. 2015;13(1):. https://doi.org/10.1186/S12964-015-0111-0.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Heasman S.J., Ridley A.J. Mammalian Rho GTPases: New Insights into Their Functions from in Vivo Studies. Nat. Rev. Mol. Cell Biol. 2008 99 2008;9(9):690-701. https://doi.org/10.1038/nrm2476.</mixed-citation><mixed-citation xml:lang="en">Heasman S.J., Ridley A.J. Mammalian Rho GTPases: New Insights into Their Functions from in Vivo Studies. Nat. Rev. Mol. Cell Biol. 2008 99 2008;9(9):690-701. https://doi.org/10.1038/nrm2476.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Suriano G., Oliveira M.J., Huntsman D., et al. E-Cadherin Germline Missense Mutations and Cell Phenotype: Evidence for the Independence of Cell Invasion on the Motile Capabilities of the Cells. Hum. Mol. Genet. 2003;12(22):3007-3016. https://doi.org/10.1093/HMG/DDG316.</mixed-citation><mixed-citation xml:lang="en">Suriano G., Oliveira M.J., Huntsman D., et al. E-Cadherin Germline Missense Mutations and Cell Phenotype: Evidence for the Independence of Cell Invasion on the Motile Capabilities of the Cells. Hum. Mol. Genet. 2003;12(22):3007-3016. https://doi.org/10.1093/HMG/DDG316.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Bremm A., Walch A., Fuchs M., et al. Enhanced Activation of Epidermal Growth Factor Receptor Caused by Tumor-Derived E-Cadherin Mutations. Cancer Res. 2008;68(3):707-714. https://doi.org/10.1158/0008-5472.CAN-07-1588.</mixed-citation><mixed-citation xml:lang="en">Bremm A., Walch A., Fuchs M., et al. Enhanced Activation of Epidermal Growth Factor Receptor Caused by Tumor-Derived E-Cadherin Mutations. Cancer Res. 2008;68(3):707-714. https://doi.org/10.1158/0008-5472.CAN-07-1588.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Mateus A.R., Seruca R., Machado J.C., et al. EGFR Regulates RhoA-GTP Dependent Cell Motility in E-Cadherin Mutant Cells. Hum. Mol. Genet. 2007;16(13):1639-1647. https://doi.org/10.1093/HMG/DDM113.</mixed-citation><mixed-citation xml:lang="en">Mateus A.R., Seruca R., Machado J.C., et al. EGFR Regulates RhoA-GTP Dependent Cell Motility in E-Cadherin Mutant Cells. Hum. Mol. Genet. 2007;16(13):1639-1647. https://doi.org/10.1093/HMG/DDM113.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Soto E., Yanagisawa M., Marlow L.A., et al. P120 Catenin Induces Opposing Effects on Tumor Cell Growth Depending on E-Cadherin Expression. J. Cell Biol. 2008;183(4):737-749. https://doi.org/10.1083/JCB.200805113.</mixed-citation><mixed-citation xml:lang="en">Soto E., Yanagisawa M., Marlow L.A., et al. P120 Catenin Induces Opposing Effects on Tumor Cell Growth Depending on E-Cadherin Expression. J. Cell Biol. 2008;183(4):737-749. https://doi.org/10.1083/JCB.200805113.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Cowell C.F., Yan I.K., Eiseler T., et al. Loss of Cell-Cell Contacts Induces NF-ΚB via RhoA-Mediated Activation of Protein Kinase D1. J. Cell. Biochem. 2009;106(4):714-728. https://doi.org/10.1002/JCB.22067.</mixed-citation><mixed-citation xml:lang="en">Cowell C.F., Yan I.K., Eiseler T., et al. Loss of Cell-Cell Contacts Induces NF-ΚB via RhoA-Mediated Activation of Protein Kinase D1. J. Cell. Biochem. 2009;106(4):714-728. https://doi.org/10.1002/JCB.22067.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Brücher B.L.D.M., Lang F., Jamall I.S. NF-ΚB Signaling and Crosstalk during Carcinogenesis. 4open 2019;2:13. https://doi.org/10.1051/FOPEN/2019010.</mixed-citation><mixed-citation xml:lang="en">Brücher B.L.D.M., Lang F., Jamall I.S. NF-ΚB Signaling and Crosstalk during Carcinogenesis. 4open 2019;2:13. https://doi.org/10.1051/FOPEN/2019010.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Sokolova O., Naumann M. NF-ΚB Signaling in Gastric Cancer. Toxins (Basel). 2017;9(4):. https://doi.org/10.3390/TOXINS9040119.</mixed-citation><mixed-citation xml:lang="en">Sokolova O., Naumann M. NF-ΚB Signaling in Gastric Cancer. Toxins (Basel). 2017;9(4):. https://doi.org/10.3390/TOXINS9040119.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Kuphal S., Poser I., Jobin C., et al. Loss of E-Cadherin Leads to Upregulation of NFkappaB Activity in Malignant Melanoma. Oncogene 2004;23(52):8509-8519. https://doi.org/10.1038/SJ.ONC.1207831.</mixed-citation><mixed-citation xml:lang="en">Kuphal S., Poser I., Jobin C., et al. Loss of E-Cadherin Leads to Upregulation of NFkappaB Activity in Malignant Melanoma. Oncogene 2004;23(52):8509-8519. https://doi.org/10.1038/SJ.ONC.1207831.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Park S.Y., Shin J.H., Kee S.H. E-Cadherin Expression Increases Cell Proliferation by Regulating Energy Metabolism through Nuclear Factor-ΚB in AGS Cells. Cancer Sci. 2017;108(9):1769-1777. https://doi.org/10.1111/CAS.13321.</mixed-citation><mixed-citation xml:lang="en">Park S.Y., Shin J.H., Kee S.H. E-Cadherin Expression Increases Cell Proliferation by Regulating Energy Metabolism through Nuclear Factor-ΚB in AGS Cells. Cancer Sci. 2017;108(9):1769-1777. https://doi.org/10.1111/CAS.13321.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Liu X., Chu K.M. E-Cadherin and Gastric Cancer: Cause, Consequence, and Applications. Biomed Res.Int. 2014;2014:. https://doi.org/10.1155/2014/637308.</mixed-citation><mixed-citation xml:lang="en">Liu X., Chu K.M. E-Cadherin and Gastric Cancer: Cause, Consequence, and Applications. Biomed Res.Int. 2014;2014:. https://doi.org/10.1155/2014/637308.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Figueiredo J., Melo S., Carneiro P., et al. Clinical Spectrum and Pleiotropic Nature of CDH1 Germline Mutations. J. Med. Genet. 2019;56(4):199-208. https://doi.org/10.1136/JMEDGENET-2018-105807.</mixed-citation><mixed-citation xml:lang="en">Figueiredo J., Melo S., Carneiro P., et al. Clinical Spectrum and Pleiotropic Nature of CDH1 Germline Mutations. J. Med. Genet. 2019;56(4):199-208. https://doi.org/10.1136/JMEDGENET-2018-105807.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Sivakumaran S., Agakov F., Theodoratou E., et al. Abundant Pleiotropy in Human Complex Diseases and Traits. Am. J. Hum. Genet. 2011;89(5):607-618. https://doi.org/10.1016/J.AJHG.2011.10.004.</mixed-citation><mixed-citation xml:lang="en">Sivakumaran S., Agakov F., Theodoratou E., et al. Abundant Pleiotropy in Human Complex Diseases and Traits. Am. J. Hum. Genet. 2011;89(5):607-618. https://doi.org/10.1016/J.AJHG.2011.10.004.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Simões-correia J., Silva D.I., Melo S., et al. DNAJB4 Molecular Chaperone Distinguishes WT from Mutant E-Cadherin, Determining Their Fate in Vitro and in Vivo. Hum. Mol. Genet. 2014;23(8):2094-2105. https://doi.org/10.1093/HMG/DDT602.</mixed-citation><mixed-citation xml:lang="en">Simões-correia J., Silva D.I., Melo S., et al. DNAJB4 Molecular Chaperone Distinguishes WT from Mutant E-Cadherin, Determining Their Fate in Vitro and in Vivo. Hum. Mol. Genet. 2014;23(8):2094-2105. https://doi.org/10.1093/HMG/DDT602.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">van der Post R.S., Vogelaar I.P., Carneiro F., et al. Hereditary Diffuse Gastric Cancer: Updated Clinical Guidelines with an Emphasis on Germline CDH1 Mutation Carriers. J. Med. Genet. 2015;52(6):361-374. https://doi.org/10.1136/JMEDGENET-2015-103094.</mixed-citation><mixed-citation xml:lang="en">van der Post R.S., Vogelaar I.P., Carneiro F., et al. Hereditary Diffuse Gastric Cancer: Updated Clinical Guidelines with an Emphasis on Germline CDH1 Mutation Carriers. J. Med. Genet. 2015;52(6):361-374. https://doi.org/10.1136/JMEDGENET-2015-103094.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Usui G., Matsusaka K., Mano Y., et al. DNA Methylation and Genetic Aberrations in Gastric Cancer. Digestion 2021;102(1):25-32. https://doi.org/10.1159/000511243.</mixed-citation><mixed-citation xml:lang="en">Usui G., Matsusaka K., Mano Y., et al. DNA Methylation and Genetic Aberrations in Gastric Cancer. Digestion 2021;102(1):25-32. https://doi.org/10.1159/000511243.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Zaraci K., Ozkinay F., Yilmaz O., et al. E-CADHERIN GENE PROMOTER METHYLATION IN PEDIATRIC ASTHMA PATHOGENESIS AND CLINICS. Eur. Respir. J. 2018;52(suppl 62):PA1300. https://doi.org/10.1183/13993003.CONGRESS-2018.PA1300.</mixed-citation><mixed-citation xml:lang="en">Zaraci K., Ozkinay F., Yilmaz O., et al. E-CADHERIN GENE PROMOTER METHYLATION IN PEDIATRIC ASTHMA PATHOGENESIS AND CLINICS. Eur. Respir. J. 2018;52(suppl 62):PA1300. https://doi.org/10.1183/13993003.CONGRESS-2018.PA1300.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Zong L., Seto Y. CpG Island Methylator Phenotype, Helicobacter Pylori, Epstein-Barr Virus, and Microsatellite Instability and Prognosis in Gastric Cancer: A Systematic Review and Meta-Analysis. PLoS One 2014;9(1): e86097 https://doi.org/10.1371/JOURNAL.PONE.0086097.</mixed-citation><mixed-citation xml:lang="en">Zong L., Seto Y. CpG Island Methylator Phenotype, Helicobacter Pylori, Epstein-Barr Virus, and Microsatellite Instability and Prognosis in Gastric Cancer: A Systematic Review and Meta-Analysis. PLoS One 2014;9(1): e86097 https://doi.org/10.1371/JOURNAL.PONE.0086097.</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Park J., Jang K.L. Hepatitis C Virus Represses E-Cadherin Expression via DNA Methylation to Induce Epithelial to Mesenchymal Transition in Human Hepatocytes. Biochem. Biophys. Res.Commun. 2014;446(2):561-567. https://doi.org/10.1016/J.BBRC.2014.03.009.</mixed-citation><mixed-citation xml:lang="en">Park J., Jang K.L. Hepatitis C Virus Represses E-Cadherin Expression via DNA Methylation to Induce Epithelial to Mesenchymal Transition in Human Hepatocytes. Biochem. Biophys. Res.Commun. 2014;446(2):561-567. https://doi.org/10.1016/J.BBRC.2014.03.009.</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Bass A.J., Thorsson V., Shmulevich I., et al.Comprehensive Molecular Characterization of Gastric Adenocarcinoma. Nat. 2014 5137517 2014;513(7517):202-209. https://doi.org/10.1038/nature13480.</mixed-citation><mixed-citation xml:lang="en">Bass A.J., Thorsson V., Shmulevich I., et al.Comprehensive Molecular Characterization of Gastric Adenocarcinoma. Nat. 2014 5137517 2014;513(7517):202-209. https://doi.org/10.1038/nature13480.</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Fukayama M., Ushiku T. Epstein-Barr Virus-Associated Gastric Carcinoma. Pathol. Res. Pract. 2011;207(9):. https://doi.org/10.1016/J.PRP.2011.07.004.</mixed-citation><mixed-citation xml:lang="en">Fukayama M., Ushiku T. Epstein-Barr Virus-Associated Gastric Carcinoma. Pathol. Res. Pract. 2011;207(9):. https://doi.org/10.1016/J.PRP.2011.07.004.</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Yamashita M., Toyota M., Suzuki H., et al. DNA Methylation of Interferon Regulatory Factors in Gastric Cancer and Noncancerous Gastric Mucosae. Cancer Sci. 2010;101(7):1708-1716. https://doi.org/10.1111/J.1349-7006.2010.01581.X.</mixed-citation><mixed-citation xml:lang="en">Yamashita M., Toyota M., Suzuki H., et al. DNA Methylation of Interferon Regulatory Factors in Gastric Cancer and Noncancerous Gastric Mucosae. Cancer Sci. 2010;101(7):1708-1716. https://doi.org/10.1111/J.1349-7006.2010.01581.X.</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Nemtsova M.V., Strelnikov V.V., Tanas A.S., et al. Implication of Gastric Cancer Molecular Genetic Markers in Surgical Practice. Curr. Genomics 2017;18(5):408. https://doi.org/10.2174/1389202918666170329110021.</mixed-citation><mixed-citation xml:lang="en">Nemtsova M.V., Strelnikov V.V., Tanas A.S., et al. Implication of Gastric Cancer Molecular Genetic Markers in Surgical Practice. Curr. Genomics 2017;18(5):408. https://doi.org/10.2174/1389202918666170329110021.</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Polk D.B., Peek R.M. Helicobacter Pylori: Gastric Cancer and Beyond. Nat. Rev. Cancer 2010;10(6):403-414. https://doi.org/10.1038/NRC2857.</mixed-citation><mixed-citation xml:lang="en">Polk D.B., Peek R.M. Helicobacter Pylori: Gastric Cancer and Beyond. Nat. Rev. Cancer 2010;10(6):403-414. https://doi.org/10.1038/NRC2857.</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Chen Y., Ren B., Yang J., et al. The Role of Histone Methylation in the Development of Digestive Cancers: A Potential Direction for Cancer Management. Signal Transduct. Target. Ther. 2020;5(1):. https://doi.org/10.1038/S41392-020-00252-1.</mixed-citation><mixed-citation xml:lang="en">Chen Y., Ren B., Yang J., et al. The Role of Histone Methylation in the Development of Digestive Cancers: A Potential Direction for Cancer Management. Signal Transduct. Target. Ther. 2020;5(1):. https://doi.org/10.1038/S41392-020-00252-1.</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Hu Y., Zheng Y., Dai M., et al. Snail2 Induced E-Cadherin Suppression and Metastasis in Lung Carcinoma Facilitated by G9a and HDACs. Cell Adh. Migr. 2019;13(1):285-292. https://doi.org/10.1080/19336918.2019.1638689.</mixed-citation><mixed-citation xml:lang="en">Hu Y., Zheng Y., Dai M., et al. Snail2 Induced E-Cadherin Suppression and Metastasis in Lung Carcinoma Facilitated by G9a and HDACs. Cell Adh. Migr. 2019;13(1):285-292. https://doi.org/10.1080/19336918.2019.1638689.</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Fukagawa A., Ishii H., Miyazawa K., et al. ΔEF1 Associates with DNMT1 and Maintains DNA Methylation of the E-Cadherin Promoter in Breast Cancer Cells. Cancer Med. 2015;4(1):125-135. https://doi.org/10.1002/CAM4.347.</mixed-citation><mixed-citation xml:lang="en">Fukagawa A., Ishii H., Miyazawa K., et al. ΔEF1 Associates with DNMT1 and Maintains DNA Methylation of the E-Cadherin Promoter in Breast Cancer Cells. Cancer Med. 2015;4(1):125-135. https://doi.org/10.1002/CAM4.347.</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Li L., Geng Y., Feng R., et al. The Human RNA Surveillance Factor UPF1 Modulates Gastric Cancer Progression by Targeting Long Non-Coding RNA MALAT1. Cell. Physiol. Biochem. 2017;42(6):2194-2206. https://doi.org/10.1159/000479994.</mixed-citation><mixed-citation xml:lang="en">Li L., Geng Y., Feng R., et al. The Human RNA Surveillance Factor UPF1 Modulates Gastric Cancer Progression by Targeting Long Non-Coding RNA MALAT1. Cell. Physiol. Biochem. 2017;42(6):2194-2206. https://doi.org/10.1159/000479994.</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Yan J., Zhang Y., She Q., et al. Long Noncoding RNA H19/MiR-675 Axis Promotes Gastric Cancer via FADD/Caspase 8/Caspase 3 Signaling Pathway. Cell. Physiol. Biochem. 2017;42(6):2364-2376. https://doi.org/10.1159/000480028.</mixed-citation><mixed-citation xml:lang="en">Yan J., Zhang Y., She Q., et al. Long Noncoding RNA H19/MiR-675 Axis Promotes Gastric Cancer via FADD/Caspase 8/Caspase 3 Signaling Pathway. Cell. Physiol. Biochem. 2017;42(6):2364-2376. https://doi.org/10.1159/000480028.</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">Yan K., Tian J., Shi W., et al. LncRNA SNHG6 Is Associated with Poor Prognosis of Gastric Cancer and Promotes Cell Proliferation and EMT through Epigenetically Silencing P27 and Sponging MiR-101-3p. Cell. Physiol. Biochem. 2017;42(3):999-1012. https://doi.org/10.1159/000478682.</mixed-citation><mixed-citation xml:lang="en">Yan K., Tian J., Shi W., et al. LncRNA SNHG6 Is Associated with Poor Prognosis of Gastric Cancer and Promotes Cell Proliferation and EMT through Epigenetically Silencing P27 and Sponging MiR-101-3p. Cell. Physiol. Biochem. 2017;42(3):999-1012. https://doi.org/10.1159/000478682.</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">Wong T.S., Gao W., Chan J.Y.W.Interactions between E-Cadherin and Microrna Deregulation in Head and Neck Cancers: The Potential Interplay. Biomed Res.Int. 2014;2014:. https://doi.org/10.1155/2014/126038.</mixed-citation><mixed-citation xml:lang="en">Wong T.S., Gao W., Chan J.Y.W.Interactions between E-Cadherin and Microrna Deregulation in Head and Neck Cancers: The Potential Interplay. Biomed Res.Int. 2014;2014:. https://doi.org/10.1155/2014/126038.</mixed-citation></citation-alternatives></ref><ref id="cit48"><label>48</label><citation-alternatives><mixed-citation xml:lang="ru">Bure I.V., Nemtsova M.V., Zaletaev D.V. Roles of E-Cadherin and Noncoding RNAs in the Epithelial-Mesenchymal Transition and Progression in Gastric Cancer.Int. J. Mol. Sci. 2019;20(12):. https://doi.org/10.3390/IJMS20122870.</mixed-citation><mixed-citation xml:lang="en">Bure I.V., Nemtsova M.V., Zaletaev D.V. Roles of E-Cadherin and Noncoding RNAs in the Epithelial-Mesenchymal Transition and Progression in Gastric Cancer.Int. J. Mol. Sci. 2019;20(12):. https://doi.org/10.3390/IJMS20122870.</mixed-citation></citation-alternatives></ref><ref id="cit49"><label>49</label><citation-alternatives><mixed-citation xml:lang="ru">Hammond S.M. An Overview of MicroRNAs. Adv. Drug Deliv. Rev. 2015;87:3-14. https://doi.org/10.1016/J.ADDR.2015.05.001.</mixed-citation><mixed-citation xml:lang="en">Hammond S.M. An Overview of MicroRNAs. Adv. Drug Deliv. Rev. 2015;87:3-14. https://doi.org/10.1016/J.ADDR.2015.05.001.</mixed-citation></citation-alternatives></ref><ref id="cit50"><label>50</label><citation-alternatives><mixed-citation xml:lang="ru">miRBase https://www.mirbase.org/(accessed 2022-05-01).</mixed-citation><mixed-citation xml:lang="en">miRBase https://www.mirbase.org/(accessed 2022-05-01).</mixed-citation></citation-alternatives></ref><ref id="cit51"><label>51</label><citation-alternatives><mixed-citation xml:lang="ru">Bure I.V., Haller F., Zaletaev D.V. Coding and Non-Coding: Molecular Portrait of GIST and Its Clinical Implication. Curr. Mol. Med. 2018;18:. https://doi.org/10.2174/1566524018666181004113436.</mixed-citation><mixed-citation xml:lang="en">Bure I.V., Haller F., Zaletaev D.V. Coding and Non-Coding: Molecular Portrait of GIST and Its Clinical Implication. Curr. Mol. Med. 2018;18:. https://doi.org/10.2174/1566524018666181004113436.</mixed-citation></citation-alternatives></ref><ref id="cit52"><label>52</label><citation-alternatives><mixed-citation xml:lang="ru">Ma D.N., Chai Z.T., Zhu X.D., et al. MicroRNA-26a Suppresses Epithelial-Mesenchymal Transition in Human Hepatocellular Carcinoma by Repressing Enhancer of Zeste Homolog 2. J. Hematol. Oncol. 2016;9(1):. https://doi.org/10.1186/S13045-015-0229-Y.</mixed-citation><mixed-citation xml:lang="en">Ma D.N., Chai Z.T., Zhu X.D., et al. MicroRNA-26a Suppresses Epithelial-Mesenchymal Transition in Human Hepatocellular Carcinoma by Repressing Enhancer of Zeste Homolog 2. J. Hematol. Oncol. 2016;9(1):. https://doi.org/10.1186/S13045-015-0229-Y.</mixed-citation></citation-alternatives></ref><ref id="cit53"><label>53</label><citation-alternatives><mixed-citation xml:lang="ru">Carvalho J., Van Grieken N.C., Pereira P.M., et al. Lack of MicroRNA-101 Causes E-Cadherin Functional Deregulation through EZH2 up-Regulation in Intestinal Gastric Cancer. J. Pathol. 2012;228(1):31-44. https://doi.org/10.1002/PATH.4032.</mixed-citation><mixed-citation xml:lang="en">Carvalho J., Van Grieken N.C., Pereira P.M., et al. Lack of MicroRNA-101 Causes E-Cadherin Functional Deregulation through EZH2 up-Regulation in Intestinal Gastric Cancer. J. Pathol. 2012;228(1):31-44. https://doi.org/10.1002/PATH.4032.</mixed-citation></citation-alternatives></ref><ref id="cit54"><label>54</label><citation-alternatives><mixed-citation xml:lang="ru">Nowek K., Wiemer E.A.C., Jongen-Lavrencic M. The Versatile Nature of MiR-9/9 * in Human Cancer. Oncotarget 2018;9(29):20838-20854. https://doi.org/10.18632/ONCOTARGET.24889.</mixed-citation><mixed-citation xml:lang="en">Nowek K., Wiemer E.A.C., Jongen-Lavrencic M. The Versatile Nature of MiR-9/9 * in Human Cancer. Oncotarget 2018;9(29):20838-20854. https://doi.org/10.18632/ONCOTARGET.24889.</mixed-citation></citation-alternatives></ref><ref id="cit55"><label>55</label><citation-alternatives><mixed-citation xml:lang="ru">Costa A.M., Ferreira R.M., Pinto-Ribeiro I., et al. Helicobacter Pylori Activates Matrix Metalloproteinase 10 in Gastric Epithelial Cells via EGFR and ERK-Mediated Pathways. J. Infect. Dis. 2016;213(11):1767-1776. https://doi.org/10.1093/INFDIS/JIW031.</mixed-citation><mixed-citation xml:lang="en">Costa A.M., Ferreira R.M., Pinto-Ribeiro I., et al. Helicobacter Pylori Activates Matrix Metalloproteinase 10 in Gastric Epithelial Cells via EGFR and ERK-Mediated Pathways. J. Infect. Dis. 2016;213(11):1767-1776. https://doi.org/10.1093/INFDIS/JIW031.</mixed-citation></citation-alternatives></ref><ref id="cit56"><label>56</label><citation-alternatives><mixed-citation xml:lang="ru">Yang Y., Li X., Du J., et al. Involvement of MicroRNAs-MMPs-E-Cadherin in the Migration and Invasion of Gastric Cancer Cells Infected with Helicobacter Pylori. Exp. Cell Res. 2018;367(2):196-204. https://doi.org/10.1016/J.YEXCR.2018.03.036.</mixed-citation><mixed-citation xml:lang="en">Yang Y., Li X., Du J., et al. Involvement of MicroRNAs-MMPs-E-Cadherin in the Migration and Invasion of Gastric Cancer Cells Infected with Helicobacter Pylori. Exp. Cell Res. 2018;367(2):196-204. https://doi.org/10.1016/J.YEXCR.2018.03.036.</mixed-citation></citation-alternatives></ref><ref id="cit57"><label>57</label><citation-alternatives><mixed-citation xml:lang="ru">Chen Z., Wu J., Huang W., et al. Long Non-Coding RNA RP11-789C1.1 Suppresses Epithelial to Mesenchymal Transition in Gastric Cancer Through the RP11-789C1.1/MiR-5003/E-Cadherin Axis. Cell. Physiol. Biochem. 2018;47(6):2432-2444. https://doi.org/10.1159/000491617.</mixed-citation><mixed-citation xml:lang="en">Chen Z., Wu J., Huang W., et al. Long Non-Coding RNA RP11-789C1.1 Suppresses Epithelial to Mesenchymal Transition in Gastric Cancer Through the RP11-789C1.1/MiR-5003/E-Cadherin Axis. Cell. Physiol. Biochem. 2018;47(6):2432-2444. https://doi.org/10.1159/000491617.</mixed-citation></citation-alternatives></ref><ref id="cit58"><label>58</label><citation-alternatives><mixed-citation xml:lang="ru">Sakamoto N., Naito Y., Oue N., et al. MicroRNA-148a Is Downregulated in Gastric Cancer, Targets MMP7, and Indicates Tumor Invasiveness and Poor Prognosis. Cancer Sci. 2014;105(2):236-243. https://doi.org/10.1111/CAS.12330.</mixed-citation><mixed-citation xml:lang="en">Sakamoto N., Naito Y., Oue N., et al. MicroRNA-148a Is Downregulated in Gastric Cancer, Targets MMP7, and Indicates Tumor Invasiveness and Poor Prognosis. Cancer Sci. 2014;105(2):236-243. https://doi.org/10.1111/CAS.12330.</mixed-citation></citation-alternatives></ref><ref id="cit59"><label>59</label><citation-alternatives><mixed-citation xml:lang="ru">Li L.Q., Pan D., Chen Q., et al. Sensitization of Gastric Cancer Cells to 5-FU by MicroRNA-204 Through Targeting the TGFBR2-Mediated Epithelial to Mesenchymal Transition. Cell. Physiol. Biochem. 2018;47(4):1533-1545. https://doi.org/10.1159/000490871.</mixed-citation><mixed-citation xml:lang="en">Li L.Q., Pan D., Chen Q., et al. Sensitization of Gastric Cancer Cells to 5-FU by MicroRNA-204 Through Targeting the TGFBR2-Mediated Epithelial to Mesenchymal Transition. Cell. Physiol. Biochem. 2018;47(4):1533-1545. https://doi.org/10.1159/000490871.</mixed-citation></citation-alternatives></ref><ref id="cit60"><label>60</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang C., Liang Y., Ma M.H., et al. Downregulation of MicroRNA-376a in Gastric Cancer and Association with Poor Prognosis. Cell. Physiol. Biochem. 2018;51(5):2010-2018. https://doi.org/10.1159/000495820.</mixed-citation><mixed-citation xml:lang="en">Zhang C., Liang Y., Ma M.H., et al. Downregulation of MicroRNA-376a in Gastric Cancer and Association with Poor Prognosis. Cell. Physiol. Biochem. 2018;51(5):2010-2018. https://doi.org/10.1159/000495820.</mixed-citation></citation-alternatives></ref><ref id="cit61"><label>61</label><citation-alternatives><mixed-citation xml:lang="ru">Cao Q., Liu F., Ji K., et al. MicroRNA-381 Inhibits the Metastasis of Gastric Cancer by Targeting TMEM16A Expression. J. Exp. Clin. Cancer Res. 2017;36(1):1-16. https://doi.org/10.1186/S13046-017-0499-Z/FIGURES/7.</mixed-citation><mixed-citation xml:lang="en">Cao Q., Liu F., Ji K., et al. MicroRNA-381 Inhibits the Metastasis of Gastric Cancer by Targeting TMEM16A Expression. J. Exp. Clin. Cancer Res. 2017;36(1):1-16. https://doi.org/10.1186/S13046-017-0499-Z/FIGURES/7.</mixed-citation></citation-alternatives></ref><ref id="cit62"><label>62</label><citation-alternatives><mixed-citation xml:lang="ru">Housman G., Byler S., Heerboth S., et al. Drug Resistance in Cancer: An Overview. Cancers (Basel). 2014;6(3):1769. https://doi.org/10.3390/CANCERS6031769.</mixed-citation><mixed-citation xml:lang="en">Housman G., Byler S., Heerboth S., et al. Drug Resistance in Cancer: An Overview. Cancers (Basel). 2014;6(3):1769. https://doi.org/10.3390/CANCERS6031769.</mixed-citation></citation-alternatives></ref><ref id="cit63"><label>63</label><citation-alternatives><mixed-citation xml:lang="ru">Liu H.T., Xing A.Y., Chen X., et al. MicroRNA-27b, MicroRNA-101 and MicroRNA-128 Inhibit Angiogenesis by down-Regulating Vascular Endothelial Growth Factor C Expression in Gastric Cancers. Oncotarget 2015;6(35):37458. https://doi.org/10.18632/ONCOTARGET.6059.</mixed-citation><mixed-citation xml:lang="en">Liu H.T., Xing A.Y., Chen X., et al. MicroRNA-27b, MicroRNA-101 and MicroRNA-128 Inhibit Angiogenesis by down-Regulating Vascular Endothelial Growth Factor C Expression in Gastric Cancers. Oncotarget 2015;6(35):37458. https://doi.org/10.18632/ONCOTARGET.6059.</mixed-citation></citation-alternatives></ref><ref id="cit64"><label>64</label><citation-alternatives><mixed-citation xml:lang="ru">Bure I.V., Kuznetsova E.B., Zaletaev D.V. Long Noncoding RNAs and Their Role in Oncogenesis. Mol. Biol. (Mosk). 2018;52(6):907-920. https://doi.org/10.1134/S0026898418060034.</mixed-citation><mixed-citation xml:lang="en">Bure I.V., Kuznetsova E.B., Zaletaev D.V. Long Noncoding RNAs and Their Role in Oncogenesis. Mol. Biol. (Mosk). 2018;52(6):907-920. https://doi.org/10.1134/S0026898418060034.</mixed-citation></citation-alternatives></ref><ref id="cit65"><label>65</label><citation-alternatives><mixed-citation xml:lang="ru">Heery R., Finn S.P., Cuffe S., et al. Long Non-Coding RNAs: Key Regulators of Epithelial-Mesenchymal Transition, Tumour Drug Resistance and Cancer Stem Cells. Cancers (Basel). 2017;9(4):. https://doi.org/10.3390/CANCERS9040038.</mixed-citation><mixed-citation xml:lang="en">Heery R., Finn S.P., Cuffe S., et al. Long Non-Coding RNAs: Key Regulators of Epithelial-Mesenchymal Transition, Tumour Drug Resistance and Cancer Stem Cells. Cancers (Basel). 2017;9(4):. https://doi.org/10.3390/CANCERS9040038.</mixed-citation></citation-alternatives></ref><ref id="cit66"><label>66</label><citation-alternatives><mixed-citation xml:lang="ru">Wang B., Yang H., Shen L., et al. Rs56288038 (C/G) in 3’UTR of IRF-1 Regulated by MiR-502-5p Promotes Gastric Cancer Development. Cell. Physiol. Biochem. 2016;40(1-2):391-399. https://doi.org/10.1159/000452554.</mixed-citation><mixed-citation xml:lang="en">Wang B., Yang H., Shen L., et al. Rs56288038 (C/G) in 3’UTR of IRF-1 Regulated by MiR-502-5p Promotes Gastric Cancer Development. Cell. Physiol. Biochem. 2016;40(1-2):391-399. https://doi.org/10.1159/000452554.</mixed-citation></citation-alternatives></ref><ref id="cit67"><label>67</label><citation-alternatives><mixed-citation xml:lang="ru">Gao S., Zhao Z.Y., Wu R., et al. Prognostic Value of Long Noncoding RNAs in Gastric Cancer: A Meta-Analysis. Onco. Targets. Ther. 2018;11:4877-4891. https://doi.org/10.2147/OTT.S169823.</mixed-citation><mixed-citation xml:lang="en">Gao S., Zhao Z.Y., Wu R., et al. Prognostic Value of Long Noncoding RNAs in Gastric Cancer: A Meta-Analysis. Onco. Targets. Ther. 2018;11:4877-4891. https://doi.org/10.2147/OTT.S169823.</mixed-citation></citation-alternatives></ref><ref id="cit68"><label>68</label><citation-alternatives><mixed-citation xml:lang="ru">Liu Y.W., Sun M., Xia R., et al. LincHOTAIR Epigenetically Silences MiR34a by Binding to PRC2 to Promote the Epithelial-to-Mesenchymal Transition in Human Gastric Cancer. Cell Death Dis. 2015;6(7):. https://doi.org/10.1038/CDDIS.2015.150.</mixed-citation><mixed-citation xml:lang="en">Liu Y.W., Sun M., Xia R., et al. LincHOTAIR Epigenetically Silences MiR34a by Binding to PRC2 to Promote the Epithelial-to-Mesenchymal Transition in Human Gastric Cancer. Cell Death Dis. 2015;6(7):. https://doi.org/10.1038/CDDIS.2015.150.</mixed-citation></citation-alternatives></ref><ref id="cit69"><label>69</label><citation-alternatives><mixed-citation xml:lang="ru">Song W., Liu Y. Y., Peng J.J., et al. Identification of Differentially Expressed Signatures of Long Non-Coding RNAs Associated with Different Metastatic Potentials in Gastric Cancer. J. Gastroenterol. 2016;51(2):119-129. https://doi.org/10.1007/S00535-015-1091-Y.</mixed-citation><mixed-citation xml:lang="en">Song W., Liu Y. Y., Peng J.J., et al. Identification of Differentially Expressed Signatures of Long Non-Coding RNAs Associated with Different Metastatic Potentials in Gastric Cancer. J. Gastroenterol. 2016;51(2):119-129. https://doi.org/10.1007/S00535-015-1091-Y.</mixed-citation></citation-alternatives></ref><ref id="cit70"><label>70</label><citation-alternatives><mixed-citation xml:lang="ru">Liu Y.Y., Chen Z.H., Peng J.J., et al. Up-Regulation of Long Non-Coding RNA XLOC_010235 Regulates Epithelial-to-Mesenchymal Transition to Promote Metastasis by Associating with Snail1 in Gastric Cancer. Sci. Rep. 2017;7(1):. https://doi.org/10.1038/S41598-017-02254-6.</mixed-citation><mixed-citation xml:lang="en">Liu Y.Y., Chen Z.H., Peng J.J., et al. Up-Regulation of Long Non-Coding RNA XLOC_010235 Regulates Epithelial-to-Mesenchymal Transition to Promote Metastasis by Associating with Snail1 in Gastric Cancer. Sci. Rep. 2017;7(1):. https://doi.org/10.1038/S41598-017-02254-6.</mixed-citation></citation-alternatives></ref><ref id="cit71"><label>71</label><citation-alternatives><mixed-citation xml:lang="ru">Pan L., Liang W., Fu M., et al. Exosomes-Mediated Transfer of Long Noncoding RNA ZFAS1 Promotes Gastric Cancer Progression. J. Cancer Res. Clin. Oncol. 2017;143(6):991-1004. https://doi.org/10.1007/S00432-017-2361-2.</mixed-citation><mixed-citation xml:lang="en">Pan L., Liang W., Fu M., et al. Exosomes-Mediated Transfer of Long Noncoding RNA ZFAS1 Promotes Gastric Cancer Progression. J. Cancer Res. Clin. Oncol. 2017;143(6):991-1004. https://doi.org/10.1007/S00432-017-2361-2.</mixed-citation></citation-alternatives></ref><ref id="cit72"><label>72</label><citation-alternatives><mixed-citation xml:lang="ru">Dong D., Mu Z., Zhao C., et al. ZFAS1: A Novel Tumor-Related Long Non-Coding RNA. Cancer Cell Int. 2018;18(1):. https://doi.org/10.1186/S12935-018-0623-Y.</mixed-citation><mixed-citation xml:lang="en">Dong D., Mu Z., Zhao C., et al. ZFAS1: A Novel Tumor-Related Long Non-Coding RNA. Cancer Cell Int. 2018;18(1):. https://doi.org/10.1186/S12935-018-0623-Y.</mixed-citation></citation-alternatives></ref><ref id="cit73"><label>73</label><citation-alternatives><mixed-citation xml:lang="ru">Chen D., Liu L., Wang K., et al. The Role of MALAT-1 in the Invasion and Metastasis of Gastric Cancer. Scand. J. Gastroenterol. 2017;52(6-7):790-796. https://doi.org/10.1080/00365521.2017.1280531.</mixed-citation><mixed-citation xml:lang="en">Chen D., Liu L., Wang K., et al. The Role of MALAT-1 in the Invasion and Metastasis of Gastric Cancer. Scand. J. Gastroenterol. 2017;52(6-7):790-796. https://doi.org/10.1080/00365521.2017.1280531.</mixed-citation></citation-alternatives></ref><ref id="cit74"><label>74</label><citation-alternatives><mixed-citation xml:lang="ru">Syllaios A., Moris D., Karachaliou G.S., et al. Pathways and Role of MALAT1 in Esophageal and Gastric Cancer (Review). Oncol. Lett. 2021;21(5):1-7. https://doi.org/10.3892/OL.2021.12604/HTML.</mixed-citation><mixed-citation xml:lang="en">Syllaios A., Moris D., Karachaliou G.S., et al. Pathways and Role of MALAT1 in Esophageal and Gastric Cancer (Review). Oncol. Lett. 2021;21(5):1-7. https://doi.org/10.3892/OL.2021.12604/HTML.</mixed-citation></citation-alternatives></ref><ref id="cit75"><label>75</label><citation-alternatives><mixed-citation xml:lang="ru">Lee N.K., Lee J.H., Ivan C., et al. MALAT1 Promoted Invasiveness of Gastric Adenocarcinoma. BMC Cancer 2017;17(1):. https://doi.org/10.1186/S12885-016-2988-4.</mixed-citation><mixed-citation xml:lang="en">Lee N.K., Lee J.H., Ivan C., et al. MALAT1 Promoted Invasiveness of Gastric Adenocarcinoma. BMC Cancer 2017;17(1):. https://doi.org/10.1186/S12885-016-2988-4.</mixed-citation></citation-alternatives></ref><ref id="cit76"><label>76</label><citation-alternatives><mixed-citation xml:lang="ru">Cai H., Chen J., He B., et al. A FOXM1 Related Long Non-Coding RNA Contributes to Gastric Cancer Cell Migration. Mol. Cell. Biochem. 2015;406(1-2):31-41. https://doi.org/10.1007/S11010-015-2421-3.</mixed-citation><mixed-citation xml:lang="en">Cai H., Chen J., He B., et al. A FOXM1 Related Long Non-Coding RNA Contributes to Gastric Cancer Cell Migration. Mol. Cell. Biochem. 2015;406(1-2):31-41. https://doi.org/10.1007/S11010-015-2421-3.</mixed-citation></citation-alternatives></ref><ref id="cit77"><label>77</label><citation-alternatives><mixed-citation xml:lang="ru">Fu M., Huang Z., Zang X., et al. Long Noncoding RNA LINC00978 Promotes Cancer Growth and Acts as a Diagnostic Biomarker in Gastric Cancer. Cell Prolif. 2018;51(1):. https://doi.org/10.1111/CPR.12425.</mixed-citation><mixed-citation xml:lang="en">Fu M., Huang Z., Zang X., et al. Long Noncoding RNA LINC00978 Promotes Cancer Growth and Acts as a Diagnostic Biomarker in Gastric Cancer. Cell Prolif. 2018;51(1):. https://doi.org/10.1111/CPR.12425.</mixed-citation></citation-alternatives></ref><ref id="cit78"><label>78</label><citation-alternatives><mixed-citation xml:lang="ru">Zuo Z.K., Gong Y., Chen X.H., et al. TGFβ1-Induced LncRNA UCA1 Upregulation Promotes Gastric Cancer Invasion and Migration. DNA Cell Biol. 2017;36(2):159-167. https://doi.org/10.1089/DNA.2016.3553.</mixed-citation><mixed-citation xml:lang="en">Zuo Z.K., Gong Y., Chen X.H., et al. TGFβ1-Induced LncRNA UCA1 Upregulation Promotes Gastric Cancer Invasion and Migration. DNA Cell Biol. 2017;36(2):159-167. https://doi.org/10.1089/DNA.2016.3553.</mixed-citation></citation-alternatives></ref><ref id="cit79"><label>79</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang E., He X., Yin D., et al. Increased Expression of Long Noncoding RNA TUG1 Predicts a Poor Prognosis of Gastric Cancer and Regulates Cell Proliferation by Epigenetically Silencing of P57. Cell Death Dis. 2016;7(2):. https://doi.org/10.1038/CDDIS.2015.356.</mixed-citation><mixed-citation xml:lang="en">Zhang E., He X., Yin D., et al. Increased Expression of Long Noncoding RNA TUG1 Predicts a Poor Prognosis of Gastric Cancer and Regulates Cell Proliferation by Epigenetically Silencing of P57. Cell Death Dis. 2016;7(2):. https://doi.org/10.1038/CDDIS.2015.356.</mixed-citation></citation-alternatives></ref><ref id="cit80"><label>80</label><citation-alternatives><mixed-citation xml:lang="ru">Sun J., Ding C., Yang Z., et al. The Long Non-Coding RNA TUG1 Indicates a Poor Prognosis for Colorectal Cancer and Promotes Metastasis by Affecting Epithelial-Mesenchymal Transition. J. Transl. Med. 2016;14(1):1-10. https://doi.org/10.1186/S12967-016-0786-Z/FIGURES/6.</mixed-citation><mixed-citation xml:lang="en">Sun J., Ding C., Yang Z., et al. The Long Non-Coding RNA TUG1 Indicates a Poor Prognosis for Colorectal Cancer and Promotes Metastasis by Affecting Epithelial-Mesenchymal Transition. J. Transl. Med. 2016;14(1):1-10. https://doi.org/10.1186/S12967-016-0786-Z/FIGURES/6.</mixed-citation></citation-alternatives></ref><ref id="cit81"><label>81</label><citation-alternatives><mixed-citation xml:lang="ru">Wang H., Chen W., Yang P., et al. Knockdown of Linc00152 Inhibits the Progression of Gastric Cancer by Regulating MicroRNA-193b-3p/ETS1 Axis. Cancer Biol. Ther. 2019;20(4):461-473. https://doi.org/10.1080/15384047.2018.1529124.</mixed-citation><mixed-citation xml:lang="en">Wang H., Chen W., Yang P., et al. Knockdown of Linc00152 Inhibits the Progression of Gastric Cancer by Regulating MicroRNA-193b-3p/ETS1 Axis. Cancer Biol. Ther. 2019;20(4):461-473. https://doi.org/10.1080/15384047.2018.1529124.</mixed-citation></citation-alternatives></ref><ref id="cit82"><label>82</label><citation-alternatives><mixed-citation xml:lang="ru">Chen D.L., Ju H.Q., Lu Y.X., et al. Long Non-Coding RNA XIST Regulates Gastric Cancer Progression by Acting as a Molecular Sponge of MiR-101 to Modulate EZH2 Expression. J. Exp. Clin. Cancer Res. 2016;35(1):. https://doi.org/10.1186/S13046-016-0420-1.</mixed-citation><mixed-citation xml:lang="en">Chen D.L., Ju H.Q., Lu Y.X., et al. Long Non-Coding RNA XIST Regulates Gastric Cancer Progression by Acting as a Molecular Sponge of MiR-101 to Modulate EZH2 Expression. J. Exp. Clin. Cancer Res. 2016;35(1):. https://doi.org/10.1186/S13046-016-0420-1.</mixed-citation></citation-alternatives></ref><ref id="cit83"><label>83</label><citation-alternatives><mixed-citation xml:lang="ru">Saito T., Kurashige J., Nambara S., et al. A Long Non-Coding RNA Activated by Transforming Growth Factor-β Is an Independent Prognostic Marker of Gastric Cancer. Ann. Surg. Oncol. 2015;22 Suppl 3:915-922. https://doi.org/10.1245/S10434-015-4554-8.</mixed-citation><mixed-citation xml:lang="en">Saito T., Kurashige J., Nambara S., et al. A Long Non-Coding RNA Activated by Transforming Growth Factor-β Is an Independent Prognostic Marker of Gastric Cancer. Ann. Surg. Oncol. 2015;22 Suppl 3:915-922. https://doi.org/10.1245/S10434-015-4554-8.</mixed-citation></citation-alternatives></ref><ref id="cit84"><label>84</label><citation-alternatives><mixed-citation xml:lang="ru">Li Y., Li D., Zhao M., et al. Long Noncoding RNA SNHG6 Regulates P21 Expression via Activation of the JNK Pathway and Regulation of EZH2 in Gastric Cancer Cells. Life Sci. 2018;208:295-304. https://doi.org/10.1016/J.LFS.2018.07.032.</mixed-citation><mixed-citation xml:lang="en">Li Y., Li D., Zhao M., et al. Long Noncoding RNA SNHG6 Regulates P21 Expression via Activation of the JNK Pathway and Regulation of EZH2 in Gastric Cancer Cells. Life Sci. 2018;208:295-304. https://doi.org/10.1016/J.LFS.2018.07.032.</mixed-citation></citation-alternatives></ref><ref id="cit85"><label>85</label><citation-alternatives><mixed-citation xml:lang="ru">Zhou X., Chen H., Zhu L., et al. Helicobacter Pylori Infection Related Long Noncoding RNA (LncRNA) AF147447 Inhibits Gastric Cancer Proliferation and Invasion by Targeting MUC2 and up-Regulating MiR-34c. Oncotarget 2016;7(50):82770-82782. https://doi.org/10.18632/ONCOTARGET.13165.</mixed-citation><mixed-citation xml:lang="en">Zhou X., Chen H., Zhu L., et al. Helicobacter Pylori Infection Related Long Noncoding RNA (LncRNA) AF147447 Inhibits Gastric Cancer Proliferation and Invasion by Targeting MUC2 and up-Regulating MiR-34c. Oncotarget 2016;7(50):82770-82782. https://doi.org/10.18632/ONCOTARGET.13165.</mixed-citation></citation-alternatives></ref><ref id="cit86"><label>86</label><citation-alternatives><mixed-citation xml:lang="ru">Zhao L., Guo H., Zhou B., et al. Long Non-Coding RNA SNHG5 Suppresses Gastric Cancer Progression by Trapping MTA2 in the Cytosol. Oncogene 2016;35(44):5770-5780. https://doi.org/10.1038/ONC.2016.110.</mixed-citation><mixed-citation xml:lang="en">Zhao L., Guo H., Zhou B., et al. Long Non-Coding RNA SNHG5 Suppresses Gastric Cancer Progression by Trapping MTA2 in the Cytosol. Oncogene 2016;35(44):5770-5780. https://doi.org/10.1038/ONC.2016.110.</mixed-citation></citation-alternatives></ref><ref id="cit87"><label>87</label><citation-alternatives><mixed-citation xml:lang="ru">Yu Y., Li L., Zheng Z., et al. Long Non-Coding RNA Linc00261 Suppresses Gastric Cancer Progression via Promoting Slug Degradation. J. Cell. Mol. Med. 2017;21(5):955-967. https://doi.org/10.1111/JCMM.13035.</mixed-citation><mixed-citation xml:lang="en">Yu Y., Li L., Zheng Z., et al. Long Non-Coding RNA Linc00261 Suppresses Gastric Cancer Progression via Promoting Slug Degradation. J. Cell. Mol. Med. 2017;21(5):955-967. https://doi.org/10.1111/JCMM.13035.</mixed-citation></citation-alternatives></ref><ref id="cit88"><label>88</label><citation-alternatives><mixed-citation xml:lang="ru">Qian Y., Shi L., Luo Z. Long Non-Coding RNAs in Cancer: Implications for Diagnosis, Prognosis, and Therapy. Front. Med. 2020;7:. https://doi.org/10.3389/FMED.2020.612393.</mixed-citation><mixed-citation xml:lang="en">Qian Y., Shi L., Luo Z. Long Non-Coding RNAs in Cancer: Implications for Diagnosis, Prognosis, and Therapy. Front. Med. 2020;7:. https://doi.org/10.3389/FMED.2020.612393.</mixed-citation></citation-alternatives></ref><ref id="cit89"><label>89</label><citation-alternatives><mixed-citation xml:lang="ru">Khaitan D., Dinger M.E., Mazar J., et al. The Melanoma-Upregulated Long Noncoding RNA SPRY4-IT1 Modulates Apoptosis and Invasion. Cancer Res. 2011;71(11):3852-3862. https://doi.org/10.1158/0008-5472.CAN-10-4460.</mixed-citation><mixed-citation xml:lang="en">Khaitan D., Dinger M.E., Mazar J., et al. The Melanoma-Upregulated Long Noncoding RNA SPRY4-IT1 Modulates Apoptosis and Invasion. Cancer Res. 2011;71(11):3852-3862. https://doi.org/10.1158/0008-5472.CAN-10-4460.</mixed-citation></citation-alternatives></ref><ref id="cit90"><label>90</label><citation-alternatives><mixed-citation xml:lang="ru">Cao D., Ding Q., Yu W., et al. Long Noncoding RNA SPRY4-IT1 Promotes Malignant Development of Colorectal Cancer by Targeting Epithelial-Mesenchymal Transition. Onco. Targets. Ther. 2016;9:5417. https://doi.org/10.2147/OTT.S111794.</mixed-citation><mixed-citation xml:lang="en">Cao D., Ding Q., Yu W., et al. Long Noncoding RNA SPRY4-IT1 Promotes Malignant Development of Colorectal Cancer by Targeting Epithelial-Mesenchymal Transition. Onco. Targets. Ther. 2016;9:5417. https://doi.org/10.2147/OTT.S111794.</mixed-citation></citation-alternatives></ref><ref id="cit91"><label>91</label><citation-alternatives><mixed-citation xml:lang="ru">Wang M., Dong X., Feng Y., et al. Prognostic Role of the Long Non-Coding RNA, SPRY4 Intronic Transcript 1, in Patients with Cancer: A Meta-Analysis. Oncotarget 2017;8(20):33713-33724. https://doi.org/10.18632/ONCOTARGET.16735.</mixed-citation><mixed-citation xml:lang="en">Wang M., Dong X., Feng Y., et al. Prognostic Role of the Long Non-Coding RNA, SPRY4 Intronic Transcript 1, in Patients with Cancer: A Meta-Analysis. Oncotarget 2017;8(20):33713-33724. https://doi.org/10.18632/ONCOTARGET.16735.</mixed-citation></citation-alternatives></ref><ref id="cit92"><label>92</label><citation-alternatives><mixed-citation xml:lang="ru">Qie P., Yin Q., Xun X., et al. Long Non-Coding RNA SPRY4-IT1 as a Promising Indicator for Three Field Lymph-Node Dissection of Thoracic Esophageal Carcinoma. J. Cardiothorac. Surg. 2021;16(1):. https://doi.org/10.1186/S13019-021-01433-X.</mixed-citation><mixed-citation xml:lang="en">Qie P., Yin Q., Xun X., et al. Long Non-Coding RNA SPRY4-IT1 as a Promising Indicator for Three Field Lymph-Node Dissection of Thoracic Esophageal Carcinoma. J. Cardiothorac. Surg. 2021;16(1):. https://doi.org/10.1186/S13019-021-01433-X.</mixed-citation></citation-alternatives></ref><ref id="cit93"><label>93</label><citation-alternatives><mixed-citation xml:lang="ru">Qiao C.F., Zhang Y., Jin L., et al. High Expression of LncRNA AFAP1-AS1 Promotes Cell Proliferation and Invasion by Inducing Epithelial-to-Mesenchymal Transition in Gastric Cancer.Int J Clin Exp Pathol 2017;10(1):393-400.</mixed-citation><mixed-citation xml:lang="en">Qiao C.F., Zhang Y., Jin L., et al. High Expression of LncRNA AFAP1-AS1 Promotes Cell Proliferation and Invasion by Inducing Epithelial-to-Mesenchymal Transition in Gastric Cancer.Int J Clin Exp Pathol 2017;10(1):393-400.</mixed-citation></citation-alternatives></ref><ref id="cit94"><label>94</label><citation-alternatives><mixed-citation xml:lang="ru">Guo J.Q., Li S.J., Guo G.X. Long Noncoding RNA AFAP1-AS1 Promotes Cell Proliferation and Apoptosis of Gastric Cancer Cells via PTEN/p-AKT Pathway. Dig. Dis. Sci. 2017;62(8):2004-2010. https://doi.org/10.1007/S10620-017-4584-0.</mixed-citation><mixed-citation xml:lang="en">Guo J.Q., Li S.J., Guo G.X. Long Noncoding RNA AFAP1-AS1 Promotes Cell Proliferation and Apoptosis of Gastric Cancer Cells via PTEN/p-AKT Pathway. Dig. Dis. Sci. 2017;62(8):2004-2010. https://doi.org/10.1007/S10620-017-4584-0.</mixed-citation></citation-alternatives></ref><ref id="cit95"><label>95</label><citation-alternatives><mixed-citation xml:lang="ru">Wu Q., Xiang S., Ma J., et al. Long Non-Coding RNA CASC15 Regulates Gastric Cancer Cell Proliferation, Migration and Epithelial Mesenchymal Transition by Targeting CDKN1A and ZEB1. Mol. Oncol. 2018;12(6):799-813. https://doi.org/10.1002/1878-0261.12187.</mixed-citation><mixed-citation xml:lang="en">Wu Q., Xiang S., Ma J., et al. Long Non-Coding RNA CASC15 Regulates Gastric Cancer Cell Proliferation, Migration and Epithelial Mesenchymal Transition by Targeting CDKN1A and ZEB1. Mol. Oncol. 2018;12(6):799-813. https://doi.org/10.1002/1878-0261.12187.</mixed-citation></citation-alternatives></ref><ref id="cit96"><label>96</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang L.L., Zhang L.F., Guo X.H., et al. Downregulation of MiR-335-5p by Long Noncoding RNA ZEB1-AS1 in Gastric Cancer Promotes Tumor Proliferation and Invasion. DNA Cell Biol. 2018;37(1):46-52. https://doi.org/10.1089/DNA.2017.3926.</mixed-citation><mixed-citation xml:lang="en">Zhang L.L., Zhang L.F., Guo X.H., et al. Downregulation of MiR-335-5p by Long Noncoding RNA ZEB1-AS1 in Gastric Cancer Promotes Tumor Proliferation and Invasion. DNA Cell Biol. 2018;37(1):46-52. https://doi.org/10.1089/DNA.2017.3926.</mixed-citation></citation-alternatives></ref><ref id="cit97"><label>97</label><citation-alternatives><mixed-citation xml:lang="ru">Fu J.W., Kong Y., Sun X. Long Noncoding RNA NEAT1 Is an Unfavorable Prognostic Factor and Regulates Migration and Invasion in Gastric Cancer. J. Cancer Res. Clin. Oncol. 2016;142(7):1571-1579. https://doi.org/10.1007/S00432-016-2152-1.</mixed-citation><mixed-citation xml:lang="en">Fu J.W., Kong Y., Sun X. Long Noncoding RNA NEAT1 Is an Unfavorable Prognostic Factor and Regulates Migration and Invasion in Gastric Cancer. J. Cancer Res. Clin. Oncol. 2016;142(7):1571-1579. https://doi.org/10.1007/S00432-016-2152-1.</mixed-citation></citation-alternatives></ref><ref id="cit98"><label>98</label><citation-alternatives><mixed-citation xml:lang="ru">Tan H.Y., Wang C., Liu G., et al. Long Noncoding RNA NEAT1-Modulated MiR-506 Regulates Gastric Cancer Development through Targeting STAT3. J. Cell. Biochem. 2019;120(4):4827-4836. https://doi.org/10.1002/JCB.26691.</mixed-citation><mixed-citation xml:lang="en">Tan H.Y., Wang C., Liu G., et al. Long Noncoding RNA NEAT1-Modulated MiR-506 Regulates Gastric Cancer Development through Targeting STAT3. J. Cell. Biochem. 2019;120(4):4827-4836. https://doi.org/10.1002/JCB.26691.</mixed-citation></citation-alternatives></ref><ref id="cit99"><label>99</label><citation-alternatives><mixed-citation xml:lang="ru">Zeng S., Xie X., Xiao Y.F., et al. Long Noncoding RNA LINC00675 Enhances Phosphorylation of Vimentin on Ser83 to Suppress Gastric Cancer Progression. Cancer Lett. 2017;412:179-187. https://doi.org/10.1016/J.CANLET.2017.10.026.</mixed-citation><mixed-citation xml:lang="en">Zeng S., Xie X., Xiao Y.F., et al. Long Noncoding RNA LINC00675 Enhances Phosphorylation of Vimentin on Ser83 to Suppress Gastric Cancer Progression. Cancer Lett. 2017;412:179-187. https://doi.org/10.1016/J.CANLET.2017.10.026.</mixed-citation></citation-alternatives></ref><ref id="cit100"><label>100</label><citation-alternatives><mixed-citation xml:lang="ru">Han Y., Ye J., Wu D., et al. LEIGC Long Non-Coding RNA Acts as a Tumor Suppressor in Gastric Carcinoma by Inhibiting the Epithelial-to-Mesenchymal Transition. BMC Cancer 2014;14(1):. https://doi.org/10.1186/1471-2407-14-932.</mixed-citation><mixed-citation xml:lang="en">Han Y., Ye J., Wu D., et al. LEIGC Long Non-Coding RNA Acts as a Tumor Suppressor in Gastric Carcinoma by Inhibiting the Epithelial-to-Mesenchymal Transition. BMC Cancer 2014;14(1):. https://doi.org/10.1186/1471-2407-14-932.</mixed-citation></citation-alternatives></ref><ref id="cit101"><label>101</label><citation-alternatives><mixed-citation xml:lang="ru">Vedove A.D., Falchi F., Donini S., et al. Structure-Based Virtual Screening Allows the Identification of Efficient Modulators of E-Cadherin-Mediated Cell-Cell Adhesion.Int. J. Mol. Sci. 2019;20(14):E3404-E3404. https://doi.org/10.3390/IJMS20143404.</mixed-citation><mixed-citation xml:lang="en">Vedove A.D., Falchi F., Donini S., et al. Structure-Based Virtual Screening Allows the Identification of Efficient Modulators of E-Cadherin-Mediated Cell-Cell Adhesion.Int. J. Mol. Sci. 2019;20(14):E3404-E3404. https://doi.org/10.3390/IJMS20143404.</mixed-citation></citation-alternatives></ref><ref id="cit102"><label>102</label><citation-alternatives><mixed-citation xml:lang="ru">Pal M., Bhattacharya S., Kalyan G., et al. Cadherin Profiling for Therapeutic Interventions in Epithelial Mesenchymal Transition (EMT) and Tumorigenesis. Exp. Cell Res. 2018;368(2):137-146. https://doi.org/10.1016/J.YEXCR.2018.04.014.</mixed-citation><mixed-citation xml:lang="en">Pal M., Bhattacharya S., Kalyan G., et al. Cadherin Profiling for Therapeutic Interventions in Epithelial Mesenchymal Transition (EMT) and Tumorigenesis. Exp. Cell Res. 2018;368(2):137-146. https://doi.org/10.1016/J.YEXCR.2018.04.014.</mixed-citation></citation-alternatives></ref><ref id="cit103"><label>103</label><citation-alternatives><mixed-citation xml:lang="ru">Shen K.H., Liao A.C.H., Hung J.H., et al. α-Solanine Inhibits Invasion of Human Prostate Cancer Cell by Suppressing Epithelial-Mesenchymal Transition and MMPs Expression. Molecules 2014;19(8):11896-11914. https://doi.org/10.3390/MOLECULES190811896.</mixed-citation><mixed-citation xml:lang="en">Shen K.H., Liao A.C.H., Hung J.H., et al. α-Solanine Inhibits Invasion of Human Prostate Cancer Cell by Suppressing Epithelial-Mesenchymal Transition and MMPs Expression. Molecules 2014;19(8):11896-11914. https://doi.org/10.3390/MOLECULES190811896.</mixed-citation></citation-alternatives></ref><ref id="cit104"><label>104</label><citation-alternatives><mixed-citation xml:lang="ru">Xie F., Liu J., Li C., et al. Simvastatin Blocks TGF-Β1-Induced Epithelial-Mesenchymal Transition in Human Prostate Cancer Cells. Oncol. Lett. 2016;11(5):3377. https://doi.org/10.3892/OL.2016.4404.</mixed-citation><mixed-citation xml:lang="en">Xie F., Liu J., Li C., et al. Simvastatin Blocks TGF-Β1-Induced Epithelial-Mesenchymal Transition in Human Prostate Cancer Cells. Oncol. Lett. 2016;11(5):3377. https://doi.org/10.3892/OL.2016.4404.</mixed-citation></citation-alternatives></ref><ref id="cit105"><label>105</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang J., Shen C., Wang L., et al. Metformin Inhibits Epithelial-Mesenchymal Transition in Prostate Cancer Cells: Involvement of the Tumor Suppressor MiR30a and Its Target Gene SOX4. Biochem. Biophys. Res.Commun. 2014;452(3):746-752. https://doi.org/10.1016/J.BBRC.2014.08.154.</mixed-citation><mixed-citation xml:lang="en">Zhang J., Shen C., Wang L., et al. Metformin Inhibits Epithelial-Mesenchymal Transition in Prostate Cancer Cells: Involvement of the Tumor Suppressor MiR30a and Its Target Gene SOX4. Biochem. Biophys. Res.Commun. 2014;452(3):746-752. https://doi.org/10.1016/J.BBRC.2014.08.154.</mixed-citation></citation-alternatives></ref><ref id="cit106"><label>106</label><citation-alternatives><mixed-citation xml:lang="ru">Blaschuk O.W. N-Cadherin Antagonists as Oncology Therapeutics. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 2015;370(1661):. https://doi.org/10.1098/RSTB.2014.0039.</mixed-citation><mixed-citation xml:lang="en">Blaschuk O.W. N-Cadherin Antagonists as Oncology Therapeutics. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 2015;370(1661):. https://doi.org/10.1098/RSTB.2014.0039.</mixed-citation></citation-alternatives></ref><ref id="cit107"><label>107</label><citation-alternatives><mixed-citation xml:lang="ru">Liu J., Sun X., Qin S., et al. CDH1 Promoter Methylation Correlates with Decreased Gene Expression and Poor Prognosis in Patients with Breast Cancer. Oncol. Lett. 2016;11(4):2635-2643. https://doi.org/10.3892/OL.2016.4274.</mixed-citation><mixed-citation xml:lang="en">Liu J., Sun X., Qin S., et al. CDH1 Promoter Methylation Correlates with Decreased Gene Expression and Poor Prognosis in Patients with Breast Cancer. Oncol. Lett. 2016;11(4):2635-2643. https://doi.org/10.3892/OL.2016.4274.</mixed-citation></citation-alternatives></ref><ref id="cit108"><label>108</label><citation-alternatives><mixed-citation xml:lang="ru">Kurata T., Fushida S., Kinoshita J., et al. Low-Dose Eribulin Mesylate Exerts Antitumor Effects in Gastric Cancer by Inhibiting Fibrosis via the Suppression of Epithelial-Mesenchymal Transition and Acts Synergistically with 5-Fluorouracil. Cancer Manag. Res. 2018;10:2729-2742. https://doi.org/10.2147/CMAR.S167846.</mixed-citation><mixed-citation xml:lang="en">Kurata T., Fushida S., Kinoshita J., et al. Low-Dose Eribulin Mesylate Exerts Antitumor Effects in Gastric Cancer by Inhibiting Fibrosis via the Suppression of Epithelial-Mesenchymal Transition and Acts Synergistically with 5-Fluorouracil. Cancer Manag. Res. 2018;10:2729-2742. https://doi.org/10.2147/CMAR.S167846.</mixed-citation></citation-alternatives></ref><ref id="cit109"><label>109</label><citation-alternatives><mixed-citation xml:lang="ru">Zhu J., Wen K. Astragaloside IV Inhibits TGF-Β1-Induced Epithelial-Mesenchymal Transition through Inhibition of the PI3K/Akt/NF-ΚB Pathway in Gastric Cancer Cells. Phytother. Res. 2018;32(7):1289-1296. https://doi.org/10.1002/PTR.6057.</mixed-citation><mixed-citation xml:lang="en">Zhu J., Wen K. Astragaloside IV Inhibits TGF-Β1-Induced Epithelial-Mesenchymal Transition through Inhibition of the PI3K/Akt/NF-ΚB Pathway in Gastric Cancer Cells. Phytother. Res. 2018;32(7):1289-1296. https://doi.org/10.1002/PTR.6057.</mixed-citation></citation-alternatives></ref><ref id="cit110"><label>110</label><citation-alternatives><mixed-citation xml:lang="ru">Li N., Zhang S., Luo Q., et al. The Effect of Dihydroartemisinin on the Malignancy and Epithelial-Mesenchymal Transition of Gastric Cancer Cells. Curr. Pharm. Biotechnol. 2019;20(9):719-726. https://doi.org/10.2174/1389201020666190611124644.</mixed-citation><mixed-citation xml:lang="en">Li N., Zhang S., Luo Q., et al. The Effect of Dihydroartemisinin on the Malignancy and Epithelial-Mesenchymal Transition of Gastric Cancer Cells. Curr. Pharm. Biotechnol. 2019;20(9):719-726. https://doi.org/10.2174/1389201020666190611124644.</mixed-citation></citation-alternatives></ref><ref id="cit111"><label>111</label><citation-alternatives><mixed-citation xml:lang="ru">Liu W.H., Yuan J.B., Zhang F., et al. Curcumin Inhibits Proliferation,Migration and Invasion of Gastric Cancer Cells via Wnt3a/β-Catenin/EMT Signaling Pathway. Zhongguo Zhong Yao Za Zhi 2019;44(14):3107-3115. https://doi.org/10.19540/J.CNKI.CJCMM.20190304.002.</mixed-citation><mixed-citation xml:lang="en">Liu W.H., Yuan J.B., Zhang F., et al. Curcumin Inhibits Proliferation,Migration and Invasion of Gastric Cancer Cells via Wnt3a/β-Catenin/EMT Signaling Pathway. Zhongguo Zhong Yao Za Zhi 2019;44(14):3107-3115. https://doi.org/10.19540/J.CNKI.CJCMM.20190304.002.</mixed-citation></citation-alternatives></ref><ref id="cit112"><label>112</label><citation-alternatives><mixed-citation xml:lang="ru">Zhao M., Ang L., Huang J., et al. MicroRNAs Regulate the Epithelial-Mesenchymal Transition and Influence Breast Cancer Invasion and Metastasis. Tumour Biol. 2017;39(2):1-8. https://doi.org/10.1177/1010428317691682.</mixed-citation><mixed-citation xml:lang="en">Zhao M., Ang L., Huang J., et al. MicroRNAs Regulate the Epithelial-Mesenchymal Transition and Influence Breast Cancer Invasion and Metastasis. Tumour Biol. 2017;39(2):1-8. https://doi.org/10.1177/1010428317691682.</mixed-citation></citation-alternatives></ref><ref id="cit113"><label>113</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang J., Li X., Huang L. Non-Viral Nanocarriers for SiRNA Delivery in Breast Cancer. J. Control. Release 2014;190:440-450. https://doi.org/10.1016/J.JCONREL.2014.05.037.</mixed-citation><mixed-citation xml:lang="en">Zhang J., Li X., Huang L. Non-Viral Nanocarriers for SiRNA Delivery in Breast Cancer. J. Control. Release 2014;190:440-450. https://doi.org/10.1016/J.JCONREL.2014.05.037.</mixed-citation></citation-alternatives></ref><ref id="cit114"><label>114</label><citation-alternatives><mixed-citation xml:lang="ru">Kjällquist U., Erlandsson R., Tobin N.P., et al. Exome Sequencing of Primary Breast Cancers with Paired Metastatic Lesions Reveals Metastasis-Enriched Mutations in the A-Kinase Anchoring Protein Family (AKAPs). BMC Cancer 2018;18(1):1-17. https://doi.org/10.1186/S12885-018-4021-6/FIGURES/3.</mixed-citation><mixed-citation xml:lang="en">Kjällquist U., Erlandsson R., Tobin N.P., et al. Exome Sequencing of Primary Breast Cancers with Paired Metastatic Lesions Reveals Metastasis-Enriched Mutations in the A-Kinase Anchoring Protein Family (AKAPs). BMC Cancer 2018;18(1):1-17. https://doi.org/10.1186/S12885-018-4021-6/FIGURES/3.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
